Cargando…

Exploring common genetic contributors to neuroprotection from amyloid pathology

Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association s...

Descripción completa

Detalles Bibliográficos
Autores principales: Seto, Mabel, Mahoney, Emily R., Dumitrescu, Logan, Ramanan, Vijay K., Engelman, Corinne D., Deming, Yuetiva, Albert, Marilyn, Johnson, Sterling C., Zetterberg, Henrik, Blennow, Kaj, Vemuri, Prashanthi, Jefferson, Angela L., Hohman, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006043/
https://www.ncbi.nlm.nih.gov/pubmed/35425899
http://dx.doi.org/10.1093/braincomms/fcac066
_version_ 1784686588598419456
author Seto, Mabel
Mahoney, Emily R.
Dumitrescu, Logan
Ramanan, Vijay K.
Engelman, Corinne D.
Deming, Yuetiva
Albert, Marilyn
Johnson, Sterling C.
Zetterberg, Henrik
Blennow, Kaj
Vemuri, Prashanthi
Jefferson, Angela L.
Hohman, Timothy J.
author_facet Seto, Mabel
Mahoney, Emily R.
Dumitrescu, Logan
Ramanan, Vijay K.
Engelman, Corinne D.
Deming, Yuetiva
Albert, Marilyn
Johnson, Sterling C.
Zetterberg, Henrik
Blennow, Kaj
Vemuri, Prashanthi
Jefferson, Angela L.
Hohman, Timothy J.
author_sort Seto, Mabel
collection PubMed
description Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association study using 5 891 064 common variants to assess whether genetic variation modifies the association between baseline beta-amyloid, as measured by both cerebrospinal fluid and positron emission tomography, and neurodegeneration defined using MRI measures of hippocampal volume. We combined and jointly analysed genotype, biomarker and neuroimaging data from non-Hispanic white individuals who were enrolled in four longitudinal ageing studies (n = 1065). Using regression models, we examined the interaction between common genetic variants (Minor Allele Frequency >0.01), including APOE-ɛ4 and APOE-ɛ2, and baseline cerebrospinal levels of amyloid (CSF Aβ42) on baseline hippocampal volume and the longitudinal rate of hippocampal atrophy. For targeted replication of top findings, we analysed an independent dataset (n = 808) where amyloid burden was assessed by Pittsburgh Compound B ([(11)C]-PiB) positron emission tomography. In this study, we found that APOE-ɛ4 modified the association between baseline CSF Aβ42 and hippocampal volume such that APOE-ɛ4 carriers showed more rapid atrophy, particularly in the presence of enhanced amyloidosis. We also identified a novel locus on chromosome 3 that interacted with baseline CSF Aβ42. Minor allele carriers of rs62263260, an expression quantitative trait locus for the SEMA5B gene (P = 1.46 × 10(−8); 3:122675327) had more rapid neurodegeneration when amyloid burden was high and slower neurodegeneration when amyloid was low. The rs62263260 × amyloid interaction on longitudinal change in hippocampal volume was replicated in an independent dataset (P = 0.0112) where amyloid burden was assessed by positron emission tomography. In addition to supporting the established interaction between APOE and amyloid on neurodegeneration, our study identifies a novel locus that modifies the association between beta-amyloid and hippocampal atrophy. Annotation results may implicate SEMA5B, a gene involved in synaptic pruning and axonal guidance, as a high-quality candidate for functional confirmation and future mechanistic analysis.
format Online
Article
Text
id pubmed-9006043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90060432022-04-13 Exploring common genetic contributors to neuroprotection from amyloid pathology Seto, Mabel Mahoney, Emily R. Dumitrescu, Logan Ramanan, Vijay K. Engelman, Corinne D. Deming, Yuetiva Albert, Marilyn Johnson, Sterling C. Zetterberg, Henrik Blennow, Kaj Vemuri, Prashanthi Jefferson, Angela L. Hohman, Timothy J. Brain Commun Original Article Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association study using 5 891 064 common variants to assess whether genetic variation modifies the association between baseline beta-amyloid, as measured by both cerebrospinal fluid and positron emission tomography, and neurodegeneration defined using MRI measures of hippocampal volume. We combined and jointly analysed genotype, biomarker and neuroimaging data from non-Hispanic white individuals who were enrolled in four longitudinal ageing studies (n = 1065). Using regression models, we examined the interaction between common genetic variants (Minor Allele Frequency >0.01), including APOE-ɛ4 and APOE-ɛ2, and baseline cerebrospinal levels of amyloid (CSF Aβ42) on baseline hippocampal volume and the longitudinal rate of hippocampal atrophy. For targeted replication of top findings, we analysed an independent dataset (n = 808) where amyloid burden was assessed by Pittsburgh Compound B ([(11)C]-PiB) positron emission tomography. In this study, we found that APOE-ɛ4 modified the association between baseline CSF Aβ42 and hippocampal volume such that APOE-ɛ4 carriers showed more rapid atrophy, particularly in the presence of enhanced amyloidosis. We also identified a novel locus on chromosome 3 that interacted with baseline CSF Aβ42. Minor allele carriers of rs62263260, an expression quantitative trait locus for the SEMA5B gene (P = 1.46 × 10(−8); 3:122675327) had more rapid neurodegeneration when amyloid burden was high and slower neurodegeneration when amyloid was low. The rs62263260 × amyloid interaction on longitudinal change in hippocampal volume was replicated in an independent dataset (P = 0.0112) where amyloid burden was assessed by positron emission tomography. In addition to supporting the established interaction between APOE and amyloid on neurodegeneration, our study identifies a novel locus that modifies the association between beta-amyloid and hippocampal atrophy. Annotation results may implicate SEMA5B, a gene involved in synaptic pruning and axonal guidance, as a high-quality candidate for functional confirmation and future mechanistic analysis. Oxford University Press 2022-03-17 /pmc/articles/PMC9006043/ /pubmed/35425899 http://dx.doi.org/10.1093/braincomms/fcac066 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Seto, Mabel
Mahoney, Emily R.
Dumitrescu, Logan
Ramanan, Vijay K.
Engelman, Corinne D.
Deming, Yuetiva
Albert, Marilyn
Johnson, Sterling C.
Zetterberg, Henrik
Blennow, Kaj
Vemuri, Prashanthi
Jefferson, Angela L.
Hohman, Timothy J.
Exploring common genetic contributors to neuroprotection from amyloid pathology
title Exploring common genetic contributors to neuroprotection from amyloid pathology
title_full Exploring common genetic contributors to neuroprotection from amyloid pathology
title_fullStr Exploring common genetic contributors to neuroprotection from amyloid pathology
title_full_unstemmed Exploring common genetic contributors to neuroprotection from amyloid pathology
title_short Exploring common genetic contributors to neuroprotection from amyloid pathology
title_sort exploring common genetic contributors to neuroprotection from amyloid pathology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006043/
https://www.ncbi.nlm.nih.gov/pubmed/35425899
http://dx.doi.org/10.1093/braincomms/fcac066
work_keys_str_mv AT setomabel exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT mahoneyemilyr exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT dumitresculogan exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT ramananvijayk exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT engelmancorinned exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT demingyuetiva exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT albertmarilyn exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT johnsonsterlingc exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT zetterberghenrik exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT blennowkaj exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT vemuriprashanthi exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT jeffersonangelal exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT hohmantimothyj exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology
AT exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology